Factor Xa inhibition by CI-1031 prevents the formation of and deaggregates thrombi in pig model Nov. 13, 2001
Phase II trial of Argatroban plus gpIIb/IIIa antagonists initiated in patients undergoing PCI Oct. 10, 2001
3-Dimensional Pharmaceuticals to receive milestone payment for thrombin inhibitor program Oct. 10, 2001
RSS